Merck (MRK) Other Non Operating Income (2009 - 2026)

Merck (MRK) has reported Other Non Operating Income for 18 consecutive years, with -$138.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income fell 494.29% year-over-year to -$138.0 million; the TTM figure through Mar 2026 stood at -$325.0 million (down 1260.71% YoY), while the FY2025 annual figure was -$151.0 million, down 729.17% from the prior year.
• Other Non Operating Income climbed to -$138.0 million in Q1 2026 per MRK's latest filing, from -$432.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $238.0 million in Q3 2025 and bottomed at -$708.0 million in Q1 2022.
• Historically, Other Non Operating Income has averaged -$131.1 million across 5 years, with a median of -$89.0 million in 2023.
• Annual changes were most pronounced in 2022 — Other Non Operating Income sank 525.24% — and 2024, when it jumped 228.57%.
• Merck's Other Non Operating Income stood at $75.0 million in 2022, then slumped by 204.0% to -$78.0 million in 2023, then tumbled by 62.82% to -$127.0 million in 2024, then tumbled by 240.16% to -$432.0 million in 2025, then jumped by 68.06% to -$138.0 million in 2026.
• Business Quant data shows MRK's Other Non Operating Income at -$138.0 million in Q1 2026, -$432.0 million in Q4 2025, and $238.0 million in Q3 2025.